Literature DB >> 3500823

An epidemiologically based follow-up study of recent arthritis. Incidence, outcome and classification.

H A Isomäki1.   

Abstract

Incidence and outcome of inflammatory joint disease (IJD) were studied by an epidemiologically based follow-up study of unselected adult arthritis patients. The annual incidence of all IJD together was 2.18% in the population of 16 years and older; 5.67% in the HLA B27 positive and 1.62% in the B27 negative population. Almost half of all arthritides were of non-specific nature. Incidence of definite rheumatoid arthritis was 0.42% per year. The outcome after 8 years was worst in seropositive rheumatoid arthritis and best in seronegative oligoarthritis of unknown etiology. Outcome of seronegative polyarthritis was bimodal: majority of patients with a favourable and minority with a poor outcome. In Yersinia arthritis, patients with a mainly IgA-class antibody response had a more severe clinical picture than those with a mainly IgG-class response. Diagnosis of rheumatoid arthritis at the early stage of the disease should be based on specific features like rheumatoid factor, radiological signs, symmetric peripheral polyarthritis and morning stiffness with a long duration. Erosive rheumatoid arthritis is almost always seropositive, at least at some stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500823     DOI: 10.1007/BF02203385

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  Letter: HL-A 27 and rheumatoid arthritis.

Authors:  H Isomäki; M Nissilä; K Koota; J Martio; A Tiilikainen
Journal:  Lancet       Date:  1974-11-16       Impact factor: 79.321

2.  Incidence of hip involvement and need for total hip replacement in rheumatoid arthritis. An eight-year follow-up study.

Authors:  M Y Lehtimäki; K Kaarela; M M Hämäläinen
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

3.  Reliability of rheumatoid factor tests.

Authors:  R von Essen; M V Lehtinen; J A Räsänen; O Wager
Journal:  Br J Rheumatol       Date:  1984-11

4.  Incidence of inflammatory rheumatic diseases in Finland.

Authors:  H Isomäki; J Raunio; R von Essen; R Hämeenkorpi
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

5.  Predicting the outcome of rheumatoid arthritis. A Soviet-Finnish co-operative study.

Authors:  H Isomäki; J Martio; S Sarna; P Kiviniemi; T Akimova; L Ievleva; N Mylov; T Trofimova
Journal:  Scand J Rheumatol       Date:  1984       Impact factor: 3.641

6.  HLA antigens in rheumatoid arthritis patients with and without a family history of polyarthritis.

Authors:  S Rantapää Dahlqvist; H Ström; A Bjelle; E Möller
Journal:  Scand J Rheumatol       Date:  1985       Impact factor: 3.641

7.  Prognostic factors and diagnostic criteria in early rheumatoid arthritis.

Authors:  K Kaarela
Journal:  Scand J Rheumatol Suppl       Date:  1985

8.  Long-term prognosis of monoarthritis. A follow-up study.

Authors:  K Kaarela; S Tiitinen; R Luukkainen
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

9.  The prediction of radiological destruction during the early stage of rheumatoid arthritis.

Authors:  R Luukkainen; K Kaarela; H Isomäki; J Martio; P Kiviniemi; J Räsänen; S Sarna
Journal:  Clin Exp Rheumatol       Date:  1983 Oct-Dec       Impact factor: 4.473

10.  Prognosis of inflammatory joint diseases. A three-year follow-up study.

Authors:  M Nissilä; H Isomäki; K Kaarela; P Kiviniemi; J Martio; S Sarna
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

View more
  4 in total

Review 1.  Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies.

Authors:  E H Choy; D L Scott
Journal:  Drugs       Date:  1995       Impact factor: 9.546

2.  The value of specific antibody detection and culture in the diagnosis of reactive arthritis.

Authors:  J Sieper; J Braun; M Reichardt; U Eggens
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

3.  A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.

Authors:  M Farr; L Waterhouse; A E Johnson; G D Kitas; R W Jubb; P A Bacon
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

4.  Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  P Machado; I Castrejon; W Katchamart; R Koevoets; B Kuriya; M Schoels; L Silva-Fernández; K Thevissen; W Vercoutere; E Villeneuve; D Aletaha; L Carmona; R Landewé; D van der Heijde; J W J Bijlsma; V Bykerk; H Canhão; A I Catrina; P Durez; C J Edwards; M D Mjaavatten; B F Leeb; B Losada; E M Martín-Mola; P Martinez-Osuna; C Montecucco; U Müller-Ladner; M Østergaard; B Sheane; R M Xavier; J Zochling; C Bombardier
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.